José Luis Martín Ventura-rekin lankidetzan egindako argitalpenak (7)

2018

  1. Lipocalin-2, a potential therapeutic target in advanced atherosclerosis

    Atherosclerosis

2016

  1. Lipocalin-2 deficiency or blockade protects against aortic abdominal aneurysm development in mice

    Cardiovascular Research, Vol. 111, Núm. 3, pp. 262-273

2014

  1. Genetic deletion or TWEAK blocking antibody administration reduce atherosclerosis and enhance plaque stability in mice

    Journal of Cellular and Molecular Medicine, Vol. 18, Núm. 4, pp. 721-734

2013

  1. Proteomic analysis of intraluminal thrombus highlights complement activation in human abdominal aortic aneurysms

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 33, Núm. 8, pp. 2013-2020

  2. Unraveling biomarkers of abdominal aortic aneurisms by iTRAQ analysis of depleted plasma

    Methods in Molecular Biology, Vol. 1000, pp. 157-166

2012

  1. Metabolomic study of plasma of patients with abdominal aortic aneurysm

    Analytical and Bioanalytical Chemistry, Vol. 403, Núm. 6, pp. 1651-1660

  2. Plasma profiling by a protein array approach identifies IGFBP-1 as a novel biomarker of abdominal aortic aneurysm

    Atherosclerosis, Vol. 221, Núm. 2, pp. 544-550